1. Michelson Diagnostics

    0 Comments Leave a Comment

    1-15 of 232 1 2 3 4 ... 14 15 16 »
    1. Mentioned In 232 Articles

    2. Defining Field Cancerization of the Skin Using Noninvasive Optical Coherence Tomography Imaging to Detect and Monitor Actinic Keratosis in Ingenol Mebutate 0.015%-Treated Patients

      Defining Field Cancerization of the Skin Using Noninvasive Optical Coherence Tomography Imaging to Detect and Monitor Actinic Keratosis in Ingenol Mebutate 0.015%-Treated Patients
      ...elson Diagnostics and Caliber ID and receives honoraria from 3Gen. Dr. Siegel is an advisory board member for Michelson Diagnostics. Ms. Schwartz, Ms. Feldman, Ms. Bieber, Ms. Bienenfeld, and Mr. Nandanan report no relev...
      Read Full Article
    3. OCT Laser Device Allows Visualization of Skin Without Biopsy

      OCT Laser Device Allows Visualization of Skin Without Biopsy
      The annual incidence of skin cancer is more than breast, colon, lung, and prostate cancer combined. Of the 7 most common skin cancers in the US melanoma is the only one whose incidence is increasing. The highest risk group for skin cancer are fair skin, adults with a history of sun exposure.
      Read Full Article
    4. Mount Sinai Health System Experts Share Skin Cancer Tips and Patient Stories for Skin Cancer Awareness Month and Melanoma Monday

      Mount Sinai Health System Experts Share Skin Cancer Tips and Patient Stories for Skin Cancer Awareness Month and Melanoma Monday
      Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. Its also one of the most preventable types of cancers. In recognition of Mays Skin Cancer Awareness Month and Melanoma Monday on May 2nd, Mount Sinai Health System experts are arming the public with vital tips on prevention and offering FREE skin cancer screenings ...
      Read Full Article
    5. Dynamic Optical Coherence Tomography in Dermatology

      Dynamic Optical Coherence Tomography in Dermatology
      Optical coherence tomography (OCT) represents a non-invasive imaging technology, which may be applied to the diagnosis of non-melanoma skin cancer and which has recently been shown to improve the diagnostic accuracy of basal cell carcinoma. Technical developments of OCT continue to expand the applicability of OCT for different neoplastic and inflammatory skin diseases. Of these, dynamic OCT (D-OCT) based on speckle variance OCT is of special interest as it allows ...
      Read Full Article
    6. Study shows VivoSight OCT is able to differentiate between actinic keratosis (AK) and basal cell carcinoma (BCC) by quantification of signal intensity and layer thickness

      Study shows VivoSight OCT is able to differentiate between actinic keratosis (AK) and basal cell carcinoma (BCC) by quantification of signal intensity and layer thickness
      ...idermal thickness and signal intensity measurements. About the VivoSight OCT System and Michelson Diagnostics Michelson Diagnostics develops, manufactures and markets the VivoSight multi-beam Optical Coherence Tomography...
      Read Full Article
    7. High-resolution label-free vascular imaging using a commercial, clinically approved dermatological OCT scanner

      High-resolution label-free vascular imaging using a commercial, clinically approved dermatological OCT scanner
      Background and Aim: Recently developed decorrelative techniques such as speckle-variance optical coherence tomography (svOCT) have demonstrated non-invasive depth-resolved imaging of the microcirculation in-vivo. However, bulk tissue motion (BTM) originating from the subject's breathing or heartbeat remains problematic at low imaging speeds, often resulting in full frame decorrelation and a loss of vascular contrast. The aim of this study was to build upon existing svOCT techniques through utilisation of a ...
      Read Full Article
    8. Comparison of different optical coherence tomography devices for diagnosis of non-melanoma skin cancer

      Comparison of different optical coherence tomography devices for diagnosis of non-melanoma skin cancer
      Purpose To compare the diagnostic imaging ability of three different optical coherence tomography (OCT) devices in non-melanoma skin cancer (NMSC). Methods Thirty actinic keratoses (AKs) and 27 basal cell carcinomas (BCCs) of 29 patients were examined with three different OCT devices, VivoSight , Callisto and Skintell . Results Complete data sets were available for 16 BCCs and 10 AKs of 18 patients. All OCT devices were able to discriminate BCCs and AKs ...
      Read Full Article
    9. Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy

      Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy
      ...chelson Diagnostics, the manufacturers of the VivoSight OCT imaging device. Dr. Markowitz is a researcher for Michelson Diagnostics and Caliber ID and receives honorarium from 3-gen. Ms. Schwartz, Ms. Feldman, Ms. Bienen...
      Read Full Article
    10. Michelson Diagnostics: Use of VivoSight OCT Scanner Significantly Improves Early-Stage Diagnosis of Basal Cell Carcinoma and Reduces Need for Skin Biopsies

      Michelson Diagnostics: Use of VivoSight OCT Scanner Significantly Improves Early-Stage Diagnosis of Basal Cell Carcinoma and Reduces Need for Skin Biopsies
      ...r.org/skin-cancer-information/basal-cell-carcinoma ) About the VivoSight OCT System and Michelson Diagnostics Michelson Diagnostics develops, manufactures and markets the VivoSight multi-beam Optical Coherence Tomography...
      Read Full Article
    11. The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study - Ulrich - 2015 - British Journal of Dermatology - Wiley Online Library

      The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study - Ulrich - 2015 - British Journal of Dermatology - Wiley Online Library
      Background The diagnostic criteria for basal cell carcinoma (BCC) using optical coherence tomography (OCT) have been described previously, but the clinical value of these findings remains unknown. Objectives To investigate the diagnostic value of OCT for BCC in a typical clinical setting. The primary efficacy end point was a diagnosis of BCC for each lesion. Secondary end points were the diagnosis of other possible conditions. Methods This was an observational ...
      Read Full Article
    12. 1-15 of 232 1 2 3 4 ... 14 15 16 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Michelson Diagnostics

    Michelson Diagnostics

    Michelson Diagnostics.  Microscopy Systems.  Michelson Diagnostics Ltd (MDL) is a healthcare company providing a live view of cancerous tissue.  The company was formed in March 2006 to develop a hand-held cancer scanner based on an imaging technology called optical coherence tomography (OCT).   The patented device will give clinicians and researchers a live view of sub-surface tissue structures at near-cellular resolution - high enough to see the emergence and growth of cancer. It shows tissue as deep as 2 mm and offers much higher image resolution than ultrasound or MRI.  The non-invasive cancer scan reduces the need for painful and costly biopsies and provides patients and doctors with immediate results. Whole organs can be systematically scanned for abnormalities.

  3. Quotes about Michelson Diagnostics

    1. I found the MedTech Tour Summit extremely useful: the high standard of presenting companies at different stages of their business development provided insights into how I need to position Michelson Diagnostics for an investment. I also made contact with several interested investors and advisors, and discussions are progressing.
      Jon Holmes in Michelson Diagnostics is Singled Out for Growth
    2. Michelson Diagnostics has applied their outstanding technology to forward thinking products and I am extremely pleased to be representing the company in the US.
      Kevin C. Oakley in Michelson Diagnostics Opens US Offices And Appoints US Business Development Manager
    3. This is a remarkable milestone for Michelson Diagnostics, as it shows, through a statistically significant sample, that multi-beam OCT technology has the potential to play an important role in the early diagnosis of cancer.
      Jon Holmes in Michelson Diagnostics Reports First Quantitative Results on Cancer Diagnosis Using Multi-beam OCT imaging